179.72 million or 64.48% of Indonesians have diabetes. 42.6% of Indonesians are at risk of developing diabetic retinopathy complications, 10% of them are at risk of blindness, and the number of diabetic retinopathy patients far exceeds the number of available doctors. This problem also increases the likelihood of patients becoming blind due to delays in early treatment and difficulties in obtaining initial analysis of symptoms.

Glucode is a revolutionary health app that empowers people with diabetic retinopathy to proactively prevent blindness. Its main feature is AI based fundus X-ray scanning.

IDEATION

1. Analyzing the results of fundus X-rays
   conducting analysis of fundus X-rays. To obtain results that correspond to fundus X-rays, we have consulted with specialists and collected fundus X-ray data to be trained by the application.

2. Initial treatment
   helping patients receive immediate initial treatment to reduce the likelihood of blindness

3. Blood sugar monitoring
   monitoring patients' blood sugar levels after conducting check-ups to provide treatment and anticipate worsening symptoms

4. Diabetic retinopathy services
   Diabetic retinopathy consultation services allow patients to connect with specialists without having to meet face-to-face. This ensures that diabetes care can still be provided effectively even when the availability of specialists is limited.